28 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/denovo-biopharma-llc-to-present-positive-phase-2b-enlighten-trial-data-for-dgm4-biomarker-guided-db104-liafensine-treatment-for-treatment-resistant-depression-at-the-ascp-2024-annual-meeting-302152321.html
LOOKING FOR A SUPPLIER?